Challenges in the Clinical Application of Advanced Technologies to Reduce Radiation-Associated Normal Tissue Injury

International Journal of Radiation Oncology Biology Physics

Volumn 69, Issue 1, 2007, Pages 4-12

  Marks, Lawrence B ^a   Ma, Jinli ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DOSIMETRY; INTENSITY MODULATED RADIATION THERAPY; PRIORITY JOURNAL; QUALITY CONTROL; RADIATION INJURY; REVIEW; TISSUE INJURY;

ANIMALS; ESOPHAGUS; HUMANS; IMAGING, THREE-DIMENSIONAL; LUNG; QUALITY ASSURANCE, HEALTH CARE; RADIATION INJURIES; RADIATION ONCOLOGY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; SPINAL CORD; TUMOR BURDEN;

EID: 34547838162     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.05.010     Document Type: Review

References (95)

1. Lichter A.S., and Ten Haken R.K. Three-dimensional treatment planning and conformal radiation dose delivery. In: De Vita V., Hellman S., and Rosenberg S.A. (Eds). Important advances in oncology (1995), JB Lippincott Publishers, Philadelphia 95-109
2. Photon Treatment Planning Collaborative Working Group. Three-dimensional display in planning radiation therapy: A clinical perspective. Int J Radiat Oncol Biol Phys 21 (1991) 79-89
3. Drzymala R.E., Mohan R., Brewster L., et al. Dose-volume histograms. Int J Radiat Oncol Biol Phys 21 (1991) 71-78
4. Kutcher G.J., Burman C., Brewster L., et al. Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations. Int J Radiat Oncol Biol Phys 21 (1991) 137-146
5. Emami B., Lyman J., Brown A., et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21 (1991) 109-122
6. Hernando M.L., Marks L.B., Bentel G.C., et al. Radiation-induced pulmonary toxicity: A dose-volume histogram analysis in 201 patients with lung cancer. Int J Radiat Oncol Biol Phys 51 (2001) 650-659
7. Kwa S.L., Lebesque J.V., Theuws J.C., et al. Radiation pneumonitis as a function of mean lung dose: An analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys 42 (1998) 1-9
8. Graham M.V., Purdy J.A., Emami B., et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 45 (1999) 323-329
9. Seppenwoolde Y., and Lebesque J.V. Partial irradiation of the lung. Semin Radiat Oncol 11 (2001) 247-258
10. Rancati T., Ceresoli G.L., Gagliardi G., et al. Factors predicting radiation pneumonitis in lung cancer patients: A retrospective study. Radiother Oncol 67 (2003) 275-283
11. Rodrigues G., Lock M., D'Souza D., et al. Prediction of radiation pneumonitis by dose-volume histogram parameters in lung cancer-A systematic review. Radiother Oncol 71 (2004) 127-138
12. Kim T.H., Cho K.H., Pyo H.R., et al. Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimensional conformal radiation therapy for lung cancer. Radiology 235 (2005) 208-215
13. Kong F.M., Hayman J.A., Griffith K.A., et al. Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): Predictors for radiation pneumonitis and fibrosis. Int J Radiat Oncol Biol Phys 65 (2006) 1075-1086
14. Wang S.L., Liao Z., Vaporciyan A.A., et al. Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery. Int J Radiat Oncol Biol Phys 64 (2006) 692-699
15. Uno T., Isobe K., Kawakami H., et al. Dose-volume factors predicting radiation pneumonitis in patients receiving salvage radiotherapy for postlobectomy locoregional recurrent non-small-cell lung cancer. Int J Clin Oncol 11 (2006) 55-59
16. Yorke E.D., Jackson A., Rosenzweig K.E., et al. Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys 54 (2002) 329-339
17. Chao K.S., Deasy J.O., Markman J., et al. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: Initial results. Int J Radiat Oncol Biol Phys 49 (2001) 907-916
18. Eisbruch A., Ship J.A., Dawson L.A., et al. Salivary gland sparing and improved target irradiation by conformal and intensity modulated irradiation of head and neck cancer. World J Surg 27 (2003) 832-837
19. Chao K.S. Protection of salivary function by intensity-modulated radiation therapy in patients with head and neck cancer. Semin Radiat Oncol 12 (2002) 20-25
20. Jackson A. Partial irradiation of the rectum. Semin Radiat Oncol 11 (2001) 215-223
21. Wachter S., Gerstner N., Goldner G., et al. Rectal sequelae after conformal radiotherapy of prostate cancer: Dose-volume histograms as predictive factors. Radiother Oncol 59 (2001) 65-70
22. Fiorino C., Sanguineti G., Cozzarini C., et al. Rectal dose-volume constraints in high-dose radiotherapy of localized prostate cancer. Int J Radiat Oncol Biol Phys 57 (2003) 953-962
23. Jackson A., Skwarchuk M.W., Zelefsky M.J., et al. Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms. Int J Radiat Oncol Biol Phys 49 (2001) 685-698
24. Boersma L.J., van den Brink M., Bruce A.M., et al. Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 GY) conformal radiotherapy for prostate cancer, using dose-volume histograms. Int J Radiat Oncol Biol Phys 41 (1998) 83-92
25. Lawrence T.S., Ten Haken R.K., Kessler M.L., et al. The use of 3-D dose volume analysis to predict radiation hepatitis. Int J Radiat Oncol Biol Phys 23 (1992) 781-788
26. Dawson L.A., Normolle D., Balter J.M., et al. Analysis of radiation-induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys 53 (2002) 810-821
27. Dawson L.A., and Ten Haken R.K. Partial volume tolerance of the liver to radiation. Semin Radiat Oncol 15 (2005) 279-283
28. Cheng J.C., Liu H.S., Wu J.K., et al. Inclusion of biological factors in parallel-architecture normal-tissue complication probability model for radiation-induced liver disease. Int J Radiat Oncol Biol Phys 62 (2005) 1150-1156
29. Liang S.X., Zhu X.D., Xu Z.Y., et al. Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: The risk factors and hepatic radiation tolerance. Int J Radiat Oncol Biol Phys 65 (2006) 426-434
30. Gagliardi G., Lax I., Rutqvist L.E., et al. Partial irradiation of the heart. Semin Radiat Oncol 11 (2001) 224-233
31. Marks L.B., Kocak Z., Zhou S., et al. The association between the mean heart dose, mean lung dose, tumor location and RT-associated heart and lung toxicity [Abstract]. Proceedings of the American Society for Therapeutic Radiology and Oncology 47th Annual Meeting. Int J Radiat Oncol Biol Phys 63 Suppl. 1 (2005) S42
32. Forster K.M., Smythe W.R., Starkschall G., et al. Intensity-modulated radiotherapy following extrapleural pneumonectomy for the treatment of malignant mesothelioma: Clinical implementation. Int J Radiat Oncol Biol Phys 55 (2003) 606-616
33. Ahamad A., Stevens C.W., Smythe W.R., et al. Intensity-modulated radiation therapy: A novel approach to the management of malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 55 (2002) 768-775
34. Levegrun S., Hof H., Essig M., et al. Radiation-induced changes of brain tissue after radiosurgery in patients with arteriovenous malformations: Correlation with dose distribution parameters. Int J Radiat Oncol Biol Phys 59 (2004) 796-808
35. Flickinger J.C., Kondziolka D., Pollock B.E., et al. Complications from arteriovenous malformation radiosurgery: Multivariate analysis and risk modeling. Int J Radiat Oncol Biol Phys 38 (1997) 485-490
36. Fan M., Marks L.B., Hollis D., et al. Can we predict radiation-induced changes in pulmonary function based on the sum of predicted regional dysfunction?. J Clin Oncol 19 (2001) 543-550
37. Eisbruch A., Ten Haken R.K., Kim H.M., et al. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 45 (1999) 577-587
38. Goitein M., Abrams M., Rowell D., et al. Multi-dimensional treatment planning: II. Beam's eye-view, back projection, and projection through CT sections. Int J Radiat Oncol Biol Phys 9 (1983) 789-797
39. Chen G.T., Spelbring D.R., Pelizzari C.A., et al. The use of beam's eye view volumetrics in the selection of non-coplanar radiation portals. Int J Radiat Oncol Biol Phys 23 (1992) 153-163
40. Verhey L.J. Comparison of three-dimensional conformal radiation therapy and intensity-modulated radiation therapy systems. Semin Radiat Oncol 9 (1999) 78-98
41. Webb S. The physical basis of IMRT and inverse planning. Br J Radiol 76 (2003) 678-689
42. Palta J.R., and Mackie T.R. Intensity-modulated radiation therapy: The state of the art: Proceedings of 2003 summer school on IMRT (2003), AAPM/Medical Physics Publishing, Madison, WI
43. Bortfeld T., Schmidt-Ullrich R., De Neve W., et al. Image-guided IMRT (2005), Springer, Berlin
44. Nutting C., Dearnaley D.P., and Webb S. Intensity modulated radiation therapy: A clinical review. Br J Radiol 73 (2000) 459-469
45. Ezzell G.A., Galvin J.M., Low D., et al. Guidance document on delivery, treatment planning, and clinical implementation of IMRT: Report of the IMRT Subcommittee of the AAPM Radiation Therapy Committee. Med Phys 30 (2003) 2089-2115
46. Brahme A. Optimization of stationary and moving beam radiation therapy techniques. Radiother Oncol 12 (1988) 129-140
47. Radiation Therapy Collaborative Working Group. Intensity-modulated radiotherapy: Current status and issues of interest. Intensity modulated. Int J Radiat Oncol Biol Phys 51 (2001) 880-914
48. Bortfeld T. IMRT: A review and preview. Phys Med Biol 51 (2006) R363-R379
49. Glatstein E. Intensity-modulated radiation therapy: The inverse, the converse, and the perverse. Semin Radiat Oncol 12 (2002) 272-281
50. Newton K.A., and Spittle M.F. An analysis of 40 cases treated by total thoracic irradiation. Clin Radiol 20 (1969) 19-22
51. Marks L.B. The pulmonary effects of thoracic irradiation. Oncology (Will Park) 8 (1994) 89-106 discussion 100, 103-104
52. Rosenzweig K., Gupta V., Jackson A., et al. Intensity-modulated radiation therapy for inoperable stage III non-small cell lung cancer [Abstract]. Proceedings of the 88th Annual Meeting of the American Radium Society. Oncology 20 Suppl. 3 (2006) 21
53. Yom S.S., Liao Z., Liu H.H., et al. Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 68 (2007) 94-102
54. Niemierko A., and Goitein M. Modeling of normal tissue response to radiation: The critical volume model. Int J Radiat Oncol Biol Phys 25 (1993) 135-145
55. Bijl H.P., van Luijk P., Coppes R.P., et al. Influence of adjacent low-dose fields on tolerance to high doses of protons in rat cervical spinal cord. Int J Radiat Oncol Biol Phys 64 (2006) 1204-1210
56. Bortfeld T. Optimized planning using physical objectives and constraints. Semin Radiat Oncol 9 (1999) 20-34
57. Penagaricano J.A., Shi C., and Ratanatharathorn V. Evaluation of integral dose in cranio-spinal axis (CSA) irradiation with conventional and helical delivery. Technol Cancer Res Treat 4 (2005) 683-689
58. Chapet O., Fraass B.A., and Ten Haken R.K. Multiple fields may offer better esophagus sparing without increased probability of lung toxicity in optimized IMRT of lung tumors. Int J Radiat Oncol Biol Phys 65 (2006) 255-265
59. Aoyama H., Westerly D.C., Mackie T.R., et al. Integral radiation dose to normal structures with conformal external beam radiation. Int J Radiat Oncol Biol Phys 64 (2006) 962-967
60. Shafman T., Marks L.M., Das S., et al. Conservation of integral-dose within, and dose-gradient between, shells surrounding targets: Physical realities and clinical consequences [Abstract]. ASTRO 44th Annual Meeting. Int J Radiat Oncol Biol Phys 54 Suppl. 1 (2002) 336
61. Fogarty G.B., Hornby C., Ferguson H.M., et al. Quality assurance in a radiation oncology unit: The chart round experience. Australas Radiol 45 (2001) 189-194
62. Kutcher G.J., Coia L., Gillin M., et al. Comprehensive QA for radiation oncology: Report of AAPM Radiation Therapy Committee Task Group 40. Med Phys 21 (1994) 581-618
63. Low D.A. Quality assurance of intensity-modulated radiotherapy. Semin Radiat Oncol 12 (2002) 219-228
64. Bentel G.C. Radiation therapy planning. 2nd ed. (1995), McGraw-Hill, New York
65. Fine L.G., Kurtz I., Woolf A.S., et al. Pathophysiology and nephron adaptation in chronic renal failure. In: Schrier R.W., and Gottschalk C.W. (Eds). Disease of the kidney. 5th ed. (1993), Little, Brown, Boston, MA 2703-2741
66. Maquet P.G.J. Biomechanics of the hip (1995), Springer Verlag, Berlin
67. Parke W.W. The anatomy of the hip. In: Balderston R.A., Rothman R.H., Booth R.E., et al. (Eds). The hip (1992), Lea Febiger, Philadelphia 3-40
68. Yorke E.D., Jackson A., Rosenzweig K.E., et al. Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study. Int J Radiat Oncol Biol Phys 63 (2005) 672-682
69. Hope A.J., Lindsay P.E., El Naqa I., et al. Modeling radiation pneumonitis risk with clinical, dosimetric, and spatial parameters. Int J Radiat Oncol Biol Phys 65 (2006) 112-124
70. Konings A.W., Cotteleer F., Faber H., et al. Volume effects and region-dependent radiosensitivity of the parotid gland. Int J Radiat Oncol Biol Phys 62 (2005) 1090-1095
71. Eisbruch A., Kim H.M., Terrell J.E., et al. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys 50 (2001) 695-704
72. Eisbruch A., Schwartz M., Rasch C., et al. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: Which anatomic structures are affected and can they be spared by IMRT?. Int J Radiat Oncol Biol Phys 60 (2004) 1425-1439
73. Lu Y., Spelbring D.R., and Chen G.T.Y. Functional dose-volume histograms for functionally heterogeneous normal organs. Phys Med Biol 42 (1997) 345-356
74. McGuire S.M., Zhou S., Marks L.B., et al. A methodology for using SPECT to reduce intensity-modulated radiation therapy (IMRT) dose to functioning lung. Int J Radiat Oncol Biol Phys 66 (2006) 1543-1552
75. Cheng C.W., and Das I.J. Treatment plan evaluation using dose-volume histogram (DVH) and spatial dose-volume histogram (zDVH). Int J Radiat Oncol Biol Phys 43 (1999) 1143-1150
76. Chao K.S., Blanco A.I., and Dempsey J.F. A conceptual model integrating spatial information to assess target volume coverage for IMRT treatment planning. Int J Radiat Oncol Biol Phys 56 (2003) 1438-1449
77. Kahn D., Zhou S., Ahn S.J., et al. "Anatomically-correct" dosimetric parameters may be better predictors for esophageal toxicity than are traditional CT-based metrics. Int J Radiat Oncol Biol Phys 62 (2005) 645-651
78. Poltinnikov I.M., Fallon K., Xiao Y., et al. Combination of longitudinal and circumferential three-dimensional esophageal dose distribution predicts acute esophagitis in hypofractionated reirradiation of patients with non-small-cell lung cancer treated in stereotactic body frame. Int J Radiat Oncol Biol Phys 62 (2005) 652-658
79. Novakova-Jiresova A., van Luijk P., van Goor H., et al. Pulmonary radiation injury: Identification of risk factors associated with regional hypersensitivity. Cancer Res 65 (2005) 3568-3576
80. van Luijk P., Novakova-Jiresova A., Faber H., et al. Radiation damage to the heart enhances early radiation-induced lung function loss. Cancer Res 65 (2005) 6509-6511
81. ICRU Report 50. Prescribing, recording, and reporting photon beam therapy (1993), International Commission on Radiation Units and Measurements, Bethesda, MD
82. ICRU Report 62. Prescribing, recording, and reporting photon beam therapy (supplement to ICRU report 50) (1999), International Commission on Radiation Units and Measurements, Bethesda, MD
83. Ling C.C., Humm J., Larson S., et al. Towards multidimensional radiotherapy (MD-CRT): Biological imaging and biological conformality. Int J Radiat Oncol Biol Phys 47 (2000) 551-560
84. Bradley J., Thorstad W.L., Mutic S., et al. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 59 (2004) 78-86
85. Ashamalla H., Rafla S., Parikh K., et al. The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer. Int J Radiat Oncol Biol Phys 63 (2005) 1016-1023
86. Rietzel E., Liu A.K., Doppke K.P., et al. Design of 4D treatment planning target volumes. Int J Radiat Oncol Biol Phys 66 (2006) 287-295
87. Herman M.G. Clinical use of electronic portal imaging. Semin Radiat Oncol 15 (2005) 157-167
88. Webb S., and Evans P.M. Innovative techniques in radiation therapy: Editorial, overview, and crystal ball gaze to the future. Semin Radiat Oncol 16 (2006) 193-198
89. Yan D., Vicini F., Wong J., et al. Adaptive radiation therapy. Phys Med Biol 42 (1997) 123-132
90. Court L.E., Tishler R.B., Petit J., et al. Automatic online adaptive radiation therapy techniques for targets with significant shape change: A feasibility study. Phys Med Biol 51 (2006) 2493-2501
91. Chen J., Morin O., Aubin M., et al. Dose-guided radiation therapy with megavoltage cone-beam CT. Br J Radiol 79 (2006) S87-S98
92. Letourneau D., Martinez A.A., Lockman D., et al. Assessment of residual error for online cone-beam CT-guided treatment of prostate cancer patients. Int J Radiat Oncol Biol Phys 62 (2005) 1239-1246
93. Pfeffer M.R., Rabin T., Tsvang L., et al. Orbital lymphoma: Is it necessary to treat the entire orbit?. Int J Radiat Oncol Biol Phys 60 (2004) 527-530
94. Senan S., van Sornsen de Koste J., Samson M., et al. Evaluation of a target contouring protocol for 3D conformal radiotherapy in non-small cell lung cancer. Radiother Oncol 53 (1999) 247-255
95. Rasch C., Steenbakkers R., and van Herk M. Target definition in prostate, head, and neck. Semin Radiat Oncol 15 (2005) 136-145